The possible cross-tolerance between morphine- and nicotine-induced hypothermia in mice

Pharmacology Biochemistry and Behavior

Volumn 68, Issue 2, 2001, Pages 283-289

  Zarrindast, Mohammad Reza ^a   Barghi Lashkari, Saoka ^a   Shafizadeh, Mahshid ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Hypothermia; Mice; Morphine; Nicotine; Tolerance

Indexed keywords

HEXAMETHONIUM; MECAMYLAMINE; MORPHINE; MORPHINE SULFATE; NALOXONE; NICOTINE; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG CROSS TOLERANCE; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; HYPOTHERMIA; LONG TERM EXPOSURE; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; BODY TEMPERATURE; DRUG INTERACTIONS; DRUG TOLERANCE; HEXAMETHONIUM; HYPOTHERMIA, INDUCED; MALE; MECAMYLAMINE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS;

ANIMALIA;

EID: 0035086367     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00457-3     Document Type: Article

References (44)

1. Characteristics of μ- and δ-opioid binding sites in striatal slices of morphine-tolerant and -dependent mice
2. The effects of nicotine on brain neurotransmitter systems
3. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self-administrative behaviour
4. Downregulation of brain and spinal cord μ-opioid in morphine tolerant-dependent rats
5. Role of serotonin and gamma-aminobutyric acid in opioid effects
6. Cholinergic modification of naloxone-induced jumping in morphine-dependent mice
7. Dopaminergic mechanisms in the locomotor stimulant effects of nicotine
8. Effect of single dose of an anticholinesterase inhibitor oxotremorine and nicotine-induced hypothermia in mice
9. Dopamine
10. Characterization and modulation of acute tolerance to nicotine in mice
11. Nicotine protects against μ-opioid receptor antagonism by β-funaltrexamine: Evidence for nicotine-induced release of endogenous opioids in brain
12. Nicotinic receptor stimulation activates enkephalin release and biosynthesis in adrenal chromaffin cell
13. Influence of genotype and sex on behavioral tolerance to nicotine in rats
14. Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity
15. Agonist action of the agonist/antagonist analgesic butrophanol on dopamine metabolism in the nucleus accumbens on the rat
16. Selective modulation of morphine antinociception, but not development of tolerance by δ receptor
17. An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice
18. Opiate actions on mesocortical dopamine metabolism in the rat
19. Dopamine and thermoregulation: An evaluation with special reference to dopaminergic pathways
20. Localization of opiate receptors in substantia nigra evidence by lesion studies
21. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
22. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors
23. Nicotine-induced tolerance and receptor changes in four mouse strains
24. Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains
25. Genotype influences on the development of tolerance to nicotine in the mouse
26. What is the nature of mecamylamine's antagonism of the central effects of nicotine?
27. The development of morphine tolerance and dependence is associated with translocation of protein kinase C
28. 2 antagonist ritanserin blocks quasi-morphine withdrawal at a time when mianserin in no longer effective
29. Presence of opiate receptors on striatal serotonergic nerve terminals
30. Tolerance to nicotine following chronic treatment by injections: A potential role for corticosterone
31. CCK receptor activation may prevent tolerance to morphine in mice
32. Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice
33. Upregulation of the opioid receptor complex by the chronic administration of morphine: A biochemical marker related to the development of tolerance and dependence
34. Reduction in the number of serotonin receptors in the brainstem of morphine-dependent rats: Relation to blockade of naloxone-precipitated jumping by serotonin agonists
35. Antibodies directed against the mu-opioid receptor alleviated multiple signs of morphine withdrawal in mice
36. In vivo homologous regulation of mu receptor gene expression in the mouse
37. Constitutive μ-opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence
38. Action of mu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function
39. Effects of delta and mu opiopeptides on the turnover and release of dopamine in rat striatum
40. Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice
41. On the mechanism(s) of morphine-induced hypothermia
42. Effects of 5-HT receptor antagonists on morphine-induced tolerance in mice
43. Nicotine-induced hypothermia through an indirect dopaminergic mechanism
44. The development of cross-tolerance between morphine and nicotine in mice